Personal information

No personal information available

Activities

Collapse all

Employment (2)

UMC Utrecht: Utrecht, NL

2017-09-01 to 2021-06-24 | MD PhD candidate (Department of Radiotherapy)
Employment
Source: Self-asserted source
Anita Werensteijn-Honingh

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2012-08 to 2015-02 | Student-assistent (Julius Center)
Employment
Source: Self-asserted source
Anita Werensteijn-Honingh

Education and qualifications (2)

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2013-09-01 to 2017-08-31 | MSc, MD Selective Utrecht Medical Master
Education
Source: Self-asserted source
Anita Werensteijn-Honingh

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2010-09-01 to 2013-07-31 | BSc Biomedical Sciences with Physics minor and Honours minor
Education
Source: Self-asserted source
Anita Werensteijn-Honingh

Works (8)

Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases

Acta Oncologica
2021-10-03 | Journal article
DOI: 10.1080/0284186X.2021.1955970
Contributors: Anita M. Werensteijn-Honingh; Anne F. J. Wevers; Max Peters; Petra S. Kroon; Martijn Intven; Wietse S. C. Eppinga; Ina M. Jürgenliemk-Schulz
Source: check_circle
Crossref

Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac

Radiotherapy and Oncology
2021-01 | Journal article
DOI: 10.1016/j.radonc.2020.09.020
Contributors: Dennis Winkel; Anita M. Werensteijn-Honingh; Wietse S.C. Eppinga; Martijn P.W. Intven; Jochem Hes; Louk M.W. Snoeren; Sanne A. Visser; Gijsbert H. Bol; Bas W. Raaymakers; Ina M. Jürgenliemk-Schulz et al.
Source: check_circle
Crossref

Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment

Radiotherapy and Oncology
2020-05 | Journal article
DOI: 10.1016/j.radonc.2020.02.011
Contributors: Dennis Winkel; Gijsbert H. Bol; Anita M. Werensteijn-Honingh; Martijn P.W. Intven; Wietse S.C. Eppinga; Jochem Hes; Louk M.W. Snoeren; Gonda G. Sikkes; Christa G.M. Gadellaa-van Hooijdonk; Bas W. Raaymakers et al.
Source: check_circle
Crossref

Adaptive radiotherapy: The Elekta Unity MR-linac concept.

Clinical and translational radiation oncology
2019-04-02 | Journal article
DOI: 10.1016/j.ctro.2019.04.001
PMID: 31341976
PMC: PMC6630157
Source: Self-asserted source
Anita Werensteijn-Honingh

Individual lymph nodes: "See it and Zap it".

Clinical and translational radiation oncology
2019-03-30 | Journal article
DOI: 10.1016/j.ctro.2019.03.004
PMID: 31341975
PMC: PMC6630103
Source: Self-asserted source
Anita Werensteijn-Honingh

Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2019-02-01 | Journal article
DOI: 10.1016/j.radonc.2019.01.024
PMID: 31005224
Source: Self-asserted source
Anita Werensteijn-Honingh

Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac.

Acta oncologica (Stockholm, Sweden)
2018-10-03 | Journal article
DOI: 10.1080/0284186x.2018.1512152
PMID: 30280631
Source: Self-asserted source
Anita Werensteijn-Honingh

Automated Hippocampal Subfield Segmentation at 7T MRI

American Journal of Neuroradiology
2016-06 | Journal article
DOI: 10.3174/ajnr.A4659
Contributors: L.E.M. Wisse; H.J. Kuijf; A.M. Honingh; H. Wang; J.B. Pluta; S.R. Das; D.A. Wolk; J.J.M. Zwanenburg; P.A. Yushkevich; M.I. Geerlings
Source: check_circle
Crossref
How many people are using ORCID?